MoneyWorks4Me

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed about the summary of proceedings of 39th Annual General Meeting of the Company held on 5th July, 2018 at ASPEE Auditorium, Laxminarayan Mandir Complex, Marve Road, Next to Nutan School, Malad (West), Mumbai - 400064.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

3560.00 19.30 (0.55%)
28-Aug-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1922.35
Dr. Reddys Labs. 1174.70
Cipla 1416.80
Lupin 2171.05
Zydus Lifesciences 1174.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: